The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas.
 
Priscilla Kaliopi Brastianos
Honoraria - Pfizer
Consulting or Advisory Role - Dantari Pharmaceuticals; ElevateBio; Pfizer; SK Life Sciences; Voyager Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst)
 
Erin Twohy
No Relationships to Disclose
 
Susan Michelle Geyer
Research Funding - Brisol-Myers-Squibb (Inst)
 
Elizabeth Robins Gerstner
Consulting or Advisory Role - Array BioPharma (I); MyoKardia (I)
 
Timothy J. Kaufmann
Stock and Other Ownership Interests - SpineThera
Consulting or Advisory Role - SpineThera
 
Michael Ruff
No Relationships to Disclose
 
Daniela Annenelie Bota
Speakers' Bureau - Novocure
 
David A. Reardon
Honoraria - Advantagene; Agenus; Bayer; Bristol-Myers Squibb; DelMar Pharmaceuticals; EMD Serono; Imvax; Medicenna; Merck; Merck KGaA; Novocure; Oncorus; Regeneron; Sumitono Dainippon Pharma; Taiho Pharmaceutical
Consulting or Advisory Role - Advantagene; Agenus; Bayer; Bristol-Myers Squibb; Delmar Pharmaceuticals; EMD Serono; Imvax; Medicenna; Merck; Merck KGaA; Novocure; Oncorus; Regeneron; Taiho Pharmaceutical
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Incyte (Inst); Omniox
 
Adam Louis Cohen
Research Funding - Abbvie (Inst); Acrotech Biopharma (Inst); AstraZeneca (Inst); BioMimetix (Inst); Bristol-Myers Squibb (Inst); Cantex (Inst); Daiichi Sankyo (Inst); Diffusion Pharmaceuticals (Inst); H3 Biomedicine (Inst); Lilly (Inst); Merrimack (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Macarena Ines De La Fuente
Consulting or Advisory Role - Agios; FORMA Therapeutics
Other Relationship - OncLIve (I); Oncology Information Group (I); Targeted Oncology (I)
 
Glenn Jay Lesser
Honoraria - BTG; SDP Oncology
Consulting or Advisory Role - Agios; Cancer Expert Now; Incysus
Research Funding - Denovo Biopharma; Global Coalition for Adaptive Research; Incyte; Novocure; Oblato
Other Relationship - ASCO; NCI
 
Jian Li Campian
Consulting or Advisory Role - Alexion Pharmaceuticals; Arbor Pharmaceuticals; Dova Pharmaceuticals; Incyte; Inovio Pharmaceuticals
Speakers' Bureau - Abbvie (I)
Research Funding - NeoImmuneTech
Travel, Accommodations, Expenses - NantWorks
 
Pankaj Agarwalla
No Relationships to Disclose
 
Priya Kumthekar
Stock and Other Ownership Interests - Vivacitas Oncology
Consulting or Advisory Role - Biocept; Biocept; ElevateBio; Janssen; Novocure; Orbus Therapeutics
Research Funding - Angiochem; DNAtrix; Genentech; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Daniel P. Cahill
Consulting or Advisory Role - Boston Pharmaceuticals; GlaxoSmithKline; Lilly
 
Helen Alice Shih
Honoraria - UpToDate
 
Paul D. Brown
Honoraria - UpToDate
 
Sandro Santagata
Consulting or Advisory Role - BioReference Laboratories
 
Frederick G. Barker
No Relationships to Disclose
 
Evanthia Galanis
Consulting or Advisory Role - Agios (Inst); Gradalis; Karyopharm Therapeutics (Inst); MedImmune (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); MedImmune (Inst); TRACON Pharma (Inst)